With the promotion of hyperbaric oxygen therapy, the application of hyperbaric oxygen chambers in China has developed rapidly.
Although the number of adverse events reported regarding hyperbaric oxygen chambers is small, their nature is serious, and the causes are mostly due to improper operation.
Therefore, relevant medical institutions are reminded to strengthen safety training and patient education, and that personnel must be certified and operate strictly according to regulations.
Furthermore, the number of people allowed inside a pure oxygen hyperbaric chamber should be strictly limited to one.
Secondly, patients are reminded to strengthen their awareness of safety precautions, strictly abide by the instructions for entering the chamber, and report any problems to medical staff promptly.
In addition, product manufacturers should proactively conduct post-marketing adverse event monitoring, collect data on any adverse events that may be related to the use of the device, report them promptly to the provincial, autonomous region, or municipal drug adverse reaction monitoring departments as required, and strictly implement relevant standards. Safety precautions should be prominently emphasized in accompanying documents (such as the instruction manual) to mitigate product usage risks.
